Atomwise’s AIMS (Artificial Intelligence Molecule Screening) project has demonstrated significant potential to accelerate drug discovery. In a landmark multiyear study published in Nature Scientific Reports, the project used Atomwise’s AI platform, AtomNet, to successfully identify structurally novel compounds across a diverse range of therapeutic targets. In the virtual high-throughput screening (HTS) study, AtomNet analyzed 318…